DaVita Newsroom

Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Announces Target Price $170

Moomoo NewsNov 6, 2024 07:31 ET

Barclays Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $164

Moomoo NewsNov 4, 2024 04:33 ET

TD Cowen Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $150

Moomoo NewsNov 1, 2024 08:35 ET

TD Cowen Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $150

Moomoo NewsOct 31, 2024 18:32 ET

DaVita Is Maintained at Equal-Weight by Barclays

Dow JonesOct 31, 2024 14:21 ET

DaVita Analyst Ratings

BenzingaOct 31, 2024 14:12 ET

Barclays Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $164

Moomoo NewsOct 31, 2024 05:33 ET

Truist Financial Maintains DaVita(DVA.US) With Hold Rating

Moomoo NewsOct 30, 2024 07:35 ET

BofA Securities Initiates DaVita(DVA.US) With Sell Rating, Announces Target Price $145

Moomoo NewsOct 30, 2024 06:31 ET

DaVita Analyst Ratings

BenzingaOct 7, 2024 08:31 ET

Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $175

Moomoo NewsOct 7, 2024 07:31 ET

DaVita Analyst Ratings

BenzingaAug 20, 2024 10:12 ET

Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Announces Target Price $165

Moomoo NewsAug 20, 2024 07:31 ET

Analysts Conflicted on These Healthcare Names: Autolus Therapeutics (AUTL), DaVita (DVA) and Bruker (BRKR)

TipRanksAug 20, 2024 07:26 ET

Key Takeaways From DaVita Analyst Ratings

BenzingaAug 8, 2024 14:00 ET

UBS Adjusts DaVita Price Target to $175 From $169, Maintains Buy Rating

MT NewswiresAug 8, 2024 10:18 ET

DaVita Price Target Raised to $175.00/Share From $169.00 by UBS

Dow JonesAug 8, 2024 09:55 ET

DaVita Analyst Ratings

BenzingaAug 7, 2024 13:11 ET

Bank of America Securities Sticks to Its Sell Rating for DaVita (DVA)

TipRanksAug 7, 2024 09:36 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Organon (OGN), Stevanato Group (STVN) and DaVita (DVA)

TipRanksAug 7, 2024 09:35 ET